Correlation Between Reneo Pharmaceuticals and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Reneo Pharmaceuticals and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reneo Pharmaceuticals and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reneo Pharmaceuticals and Caribou Biosciences, you can compare the effects of market volatilities on Reneo Pharmaceuticals and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reneo Pharmaceuticals with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reneo Pharmaceuticals and Caribou Biosciences.
Diversification Opportunities for Reneo Pharmaceuticals and Caribou Biosciences
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Reneo and Caribou is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Reneo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reneo Pharmaceuticals are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Reneo Pharmaceuticals i.e., Reneo Pharmaceuticals and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Reneo Pharmaceuticals and Caribou Biosciences
If you would invest 1,820 in Reneo Pharmaceuticals on September 30, 2024 and sell it today you would earn a total of 0.00 from holding Reneo Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Reneo Pharmaceuticals vs. Caribou Biosciences
Performance |
Timeline |
Reneo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Strong
Caribou Biosciences |
Reneo Pharmaceuticals and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Reneo Pharmaceuticals and Caribou Biosciences
The main advantage of trading using opposite Reneo Pharmaceuticals and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reneo Pharmaceuticals position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.Reneo Pharmaceuticals vs. Prime Medicine, Common | Reneo Pharmaceuticals vs. Ginkgo Bioworks Holdings | Reneo Pharmaceuticals vs. Ocean Biomedical | Reneo Pharmaceuticals vs. Royalty Pharma Plc |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |